Company Profile
Beijing AblePharmtech Co.,Ltd owns a complete professional team, including medicine synthetics, analysis and formulation, production and sales, equipped with advanced R&D facilities and standardized research laboratories.The strict scientific research and production management rules are set up. In 2014, the company was evaluated as “the State High Technology Enterprise”.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
Alvimopan intermediate I |
Phenol,3-[(3R,4R)-3,4-dimethyl-4-piperidinyl]-;Phenol,3-(3,4-dimethyl-4-piperidinyl)-,(3R-cis)-;3-[(3R,4R)-3,4-Dimethyl-4-piperidinyl]phenol;(+)-(3R,4R)-Dimethyl-4-(3-hydroxyphenyl)piperidine;(+)-(3R,4R)-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine;(3R,4R)-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine;(3R,4R)-3-(3,4-Dimethyl-4-piperidinyl)phenol |
119193-19-0 | Inquiry | |
Alvimopan intermediate II |
1-Piperidinepropanoic acid,4-(3-hydroxyphenyl)-3,4-dimethyl-α-(phenylmethyl)-,methyl ester,hydrochloride (1:1),(αS,3R,4R)-;1-Piperidinepropanoic acid,4-(3-hydroxyphenyl)-3,4-dimethyl-α-(phenylmethyl)-,methyl ester,hydrochloride,[3R-[1(S*),3α,4α]]-;1-Piperidinepropanoic acid,4-(3-hydroxyphenyl)-3,4-dimethyl-α-(phenylmethyl)-,methyl ester,hydrochloride,(αS,3R,4R)-;(3R,4R)-1-((2S)-2-Benzyl-3-methoxy-3-oxopropyl)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidine hydrochloride |
170098-28-9 | Inquiry | |
Brivaracetam |
1-Pyrrolidineacetamide,α-ethyl-2-oxo-4-propyl-,(αS,4R)-;(αS,4R)-α-Ethyl-2-oxo-4-propyl-1-pyrrolidineacetamide;UCB 34714;Brivaracetam;Briviact;1-Pyrrolidineacetamide α-ethyl-2-oxo-4-propyl-,(αS,4R)-;(2S)-2-[(4R)-2-Oxo-4-propyl-1-pyrrolidinyl]butanamide;2375745-81-4 |
357336-20-0 | Inquiry | |
Finafloxacin Intermediate II |
(4aS,7aS)-octahydropyrrolo[3,4-b][1,4]oxazine;1S,6S-2-oxa-5,8-diazabicyclo[4.3.0]nonane;Pyrrolo[3,4-b]-1,4-oxazine, octahydro-, (4aS,7aS)- |
209401-69-4 | Inquiry | |
Gamithromycin |
1-Oxa-7-azacyclopentadecan-15-one,13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-7-propyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-,(2R,3S,4R,5S,8R,10R,11R,12S,13S,14R)-;1-Oxa-7-azacyclopentadecan-15-one,13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-7-propyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-,[2R-(2R*,3S*,4R*,5S*,8R*,10R*,11R*,12S*,13S*,14R*)]-;(2R,3S,4R,5S,8R,10R,11R,12S,13S,14R)-13-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-7-propyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-1-oxa-7-azacyclopentadecan-15-one;ML 1709460;Gamithromycin;Zactran;255042-08-1 |
145435-72-9 | Inquiry | |
Micafungin intermediate |
179162-55-1 | Inquiry | ||
Omarigliptin |
2H-Pyran-3-amine,2-(2,5-difluorophenyl)-5-[2,6-dihydro-2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-,(2R,3S,5R)-;(2R,3S,5R)-2-(2,5-Difluorophenyl)-5-[2,6-dihydro-2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine;(2R,3S,5R)-2-(2,5-Difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine;Omarigliptin;1446021-64-2 |
1226781-44-7 | Inquiry | |
Riociguat |
Carbamic acid,N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methyl-,methyl ester;Carbamic acid,[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]methyl-,methyl ester;Riociguat;BAY 632521;BAY 63-2521;Methyl [4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]methylcarbamate;Adempas;Methyl N-[4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-(methyl)carbamate;911138-23-3 |
625115-55-1 | Inquiry | |
Topiroxostat |
2-Pyridinecarbonitrile,4-[3-(4-pyridinyl)-1H-1,2,4-triazol-5-yl]-;2-Pyridinecarbonitrile,4-[5-(4-pyridinyl)-1H-1,2,4-triazol-3-yl]-;4-[3-(4-Pyridinyl)-1H-1,2,4-triazol-5-yl]-2-pyridinecarbonitrile;5-(2-Cyano-4-pyridyl)-3-(4-pyridyl)-1,2,4-triazole;FYX 051;Topiroxostat |
577778-58-6 | Inquiry | |
Vonoprazan Fumarate |
1H-Pyrrole-3-methanamine,5-(2-fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-;5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine;1-[5-(2-Fluorophenyl)-1-[(pyridin-3-yl)sulfonyl]-1H-pyrrol-3-yl]-N-methylmethanamine;Vonoprazan;TAK 438 free form |
881681-00-1 | Inquiry | |
Vonoprazan Fumarate intermediate |
1H-Pyrrole-3-carboxaldehyde,5-(2-fluorophenyl)-;5-(2-Fluorophenyl)-1H-pyrrole-3-carboxaldehyde |
881674-56-2 | Inquiry | |
Vonoprazan Intermediate |
3-CHLOROSULFONYL-PYRIDINIUM, CHLORIDE;3-PYRIDINESULFONYL CHLORIDE, HCL;3-PYRIDINESULFONYL CHLORIDE HYDROCHLORIDE;PYRIDINE-3-SULPHONYL CHLORIDE HYDROCHLORIDE;m-Pyridinesulfonyl chloride;Piperidine-3-sulfonylchloride;Vonoprazan intermediate;pyridine-3-sulfonyl chloride(SALTDATA: 0.8HCl 0.3H2O) |
16133-25-8 | Inquiry |